Overview

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Status:
Completed
Trial end date:
2016-07-22
Target enrollment:
Participant gender:
Summary
To investigate the factors that affect Aricept medication persistence rate and the safety and efficacy in patients with Alzheimer's Disease in clinical practice
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Donepezil